BlackRock »

Inmune Bio Ord shares owned by BlackRock

Quarter-by-quarter ownership of Inmune Bio Ord (INMB) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Inmune Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Inmune Bio Ord held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmune Bio Ord by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.1M 940k 5.39

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Inmune Bio Ord

BlackRock
BlackRock
Praetorian PR
Vanguard Group
CVI Holdings
Raymond James Financial Services Advisors
Geode Capital Management
Susquehanna International
State Street Corporation
MAI Wealth Advisors
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Renaissance Technologies
Northern Trust
Marshall Wace

View all funds holding Inmune Bio Ord